Tid Tittel Kategori Vedlegg
20.02.2026
14:30
Zelluna mottar UK MHRA og etisk godkjenning for oppstart av ZIMA-101 første-i-menneske klinisk studie - -
20.02.2026
14:30
Zelluna Receives UK MHRA and Ethics Approval to Initiate ZIMA-101 First-in-Human Clinical Trial - -
12.02.2026
07:00
Zelluna ASA: Fjerde kvartal 2025 - Viktig regulatorisk milepæl oppnådd med CTA-innlevering -
2
12.02.2026
07:00
Zelluna ASA: Fourth Quarter 2025 - Key regulatory milestone achieved with CTA Submission -
2
11.02.2026
08:00
Zelluna inngår avtale med Medpace om første kliniske studie - pasientdata ventes fra medio 2026 - -
11.02.2026
08:00
Zelluna selects Medpace as CRO for ZIMA-101 first-in-human clinical trial - -
05.02.2026
13:30
Zelluna ASA - Grant of Share Options - -
05.02.2026
09:30
Zelluna ASA: Invitation to Fourth Quarter 2025 Results Webcast Presentation - -
03.02.2026
08:00
Zelluna utnevner Emilie Gauthy til Chief Technology Officer - -
03.02.2026
08:00
Zelluna promotes Emilie Gauthy to Chief Technology Officer - -
15.01.2026
12:22
Zelluna ASA: Approval and publication of prospectus - -
17.12.2025
17:26
Zelluna Reaches Major Milestone and Submits Clinical Trial Application in the UK for First-in-Human Study of ZI-MA4-1 (ZIMA-101), the World's First MAGE-A4-Targeting TCR-NK Cell Therapy for Solid Tumours - -
17.12.2025
17:26
Zelluna har nådd en viktig milepæl og innleverer søknad om klinisk studie i Storbritannia for første studie på mennesker av ZI-MA4-1 (ZIMA-101), verdens første MAGE-A4-rettede TCR-NK celleterapi for solide kreftformer. - -
16.12.2025
12:36
Zelluna Publishes Compelling Preclinical Data for ZI-MA4-1, the World's First MAGE-A4-Targeting TCR-NK Therapy for Solid Tumours - -
12.12.2025
13:02
Zelluna Completes First GMP Batch of ZI-MA4-1, a Novel TCR-NK Cell Therapy, to Treat Patients in Upcoming First-in-Human Trial - -
09.12.2025
09:36
Zelluna ASA: Cancellation of subsequent repair offering - -
08.12.2025
18:36
Zelluna ASA - Mandatory notification of trade STORAKSJONÆR AKS
1
08.12.2025
13:52
Zelluna ASA: New share capital registered - -
28.11.2025
07:50
Zelluna ASA Announces Appointment of Geir Christian Melen as New Chief Financial Officer - -
27.11.2025
08:35
Zelluna ASA: Disclosure of large shareholding STORAKSJONÆR AKS -
25.11.2025
16:05
Zelluna ASA: Disclosure of large shareholding STORAKSJONÆR AKS -
25.11.2025
12:09
ZELLUNA ASA: DISCLOSURE OF LARGE SHAREHOLDING STORAKSJONÆR AKS -
25.11.2025
11:32
Zelluna ASA - Extraordinary General Meeting held on November 25, 2025 -
2
17.11.2025
10:33
Zelluna ASA: New share capital registered - -
04.11.2025
13:04
Zelluna ASA: Notice of extraordinary general meeting on 25 November 2025 -
1